Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: Research: Compendia: Research Models: APP Mutations
NORBA

General Information

Transgene: Human βAPP cDNA carboxy terminal 99 a.a. and βAPP signal peptide (without AD-specific mutations)

Mutation: none

Promoter: cytomegalovirus enhancer/chicken β-actin

Mouse Strain: B6C3F1 x C57BL/6N hybrid

Phenotype

Neuropathological Analysis:

Accumulation of human Aβ at very high level in pancreas (8600 pmol/g) and in lesser, though readily detectable, amounts in brain (4.1 pmol/g) and kidney (15.0 pmol/g).

Little correlation between Aβ accumulation and the expression of transgenic mRNA because Aβ was not detected in tissues such liver and heart which expressed more transgenic mRNA than pancreas, brain, or kidney.

Accumulation of human Aβ in transgenic plasma in an amount over 30 times that in normal human plasma.

Putative amyloid fibrils in pancreas both in acinar cells and in interstitial macrophages. Like amyloid fibrils in the AD brain, these fibrils had a diameter of 7-12 nm and were stained by anti-Aβ antibody.

Behavioral:

N/A

Availability

Patents: None

Reference

Primary:

Kawarabayashi T, Shoji M, Sato M, Sasaki A, Ho L, Eckman CB, Prada C-M, Younkin SG, Kobayashi T, Norihiro T, Matsubara E, Iizuka T, Harigaya Y, Kasai K, Hirai S. Accumulation of β-amyloid fibrils in pancreas of transgenic mice. Neurobiol Aging. 1996;17(2):215-22. Abstract .

Associated:

Shoji M, Kawarabayashi T, Sato M, Sasaki A, Saido TC, Matsubara E, Tomidokoro Y, Kanai M, Shizuka M, Ishiguro K, Ikeda M, Harigaya Y, Okamoto K, Hirai S. Age-related amyloid β protein accumulation induces cellular death and macrophage activation in transgenic mice. J Pathol 2000 May;191(1):93-101. Abstract.

Shoji M, Kawarabayashi T, Sato M, Sasaki A, Matsubara E, Igeta Y, Kanai M, Tomidokoro Y, Shizuka M, Ishiguro K, Harigaya Y, Okamoto K, Hirai S. Accumulation of amyloid β protein in transgenic mice. Neurobiol Aging 1998 Jan-Feb;19(1 Suppl):S59-63. Abstract .

Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark

See recent updates
Alzheimer's Disease Mouse Model Resource
Considerations for Choosing Controls
Research Tools

Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad